tiprankstipranks
Prime Medicine, Inc. (PRME)
NASDAQ:PRME
US Market

Prime Medicine, Inc. (PRME) Income Statement

Compare
594 Followers

Prime Medicine, Inc. Income Statement

Last quarter (Q3 2024), Prime Medicine, Inc.'s total revenue was $209.00K, an increase of Infinity% from the same quarter last year. In Q3, Prime Medicine, Inc.'s net income was $-52.52M. See Prime Medicine, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 5.21M$ 0.00
Gross Profit
$ -147.91M$ 0.00$ 0.00$ 0.00$ -2.76M
Operating Expenses
$ 186.64M$ 116.54M$ 84.47M$ 6.14M$ 2.17M
Depreciation and Amortization
$ 4.65M$ 12.01M$ 4.86M$ 43.00K$ 6.52M
EBITDA
$ -193.76M$ -110.75M$ -160.99M$ -889.00K$ -2.17M
Operating Income
$ -191.29M$ -116.54M$ -84.47M$ -932.00K$ -2.17M
Other Income/Expenses
$ -7.12M$ -6.22M$ -81.38M$ -611.00K$ 3.99M
Pretax Income
$ -198.41M$ -122.77M$ -165.85M$ -1.54M$ -2.52M
Net Income
$ -198.13M$ -121.82M$ -165.37M$ -3.41M$ -2.53M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.18$ -1.25$ -2.55$ -0.07$ -0.03
Diluted EPS
$ -2.18$ -1.25$ -2.55$ -0.07$ -0.03
Weighted Average Shares Outstanding
90.97M 97.21M 64.90M 71.80M 95.73M
Weighted Average Shares Outstanding (Diluted)
90.97M 97.21M 64.90M 71.80M 95.73M
Currency in USD

Prime Medicine, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis